Clinical trials
Polycystic Ovary Syndrome trials in Egypt
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
103 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 10 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 12 |
| 2024 | 10 |
| 2025 | 9 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 62 |
| Unknown status | 23 |
| Recruiting | 10 |
| Not yet recruiting | 3 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 29 |
| Ain Shams University | 11 |
| Mansoura University | 10 |
| Beni-Suef University | 8 |
| Assiut University | 7 |
| Kafrelsheikh University | 4 |
| Ain Shams Maternity Hospital | 3 |
| Al-Azhar University | 3 |
| Egymedicalpedia | 3 |
| Mohamed Sayed Abdelhafez | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycystic Ovary Syndrome | 103 |
| Infertility | 15 |
| Infertility, Female | 3 |
| Insulin Resistance | 3 |
| Obesity | 3 |
| Dry Eye Syndromes | 2 |
| Anovulation | 1 |
| Asthma | 1 |
| Autoimmune Diseases | 1 |
| Body Weight | 1 |
Trials
Showing 26 to 50 of 103. Each trial links to its page on Pharma Observatory.
3 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.